Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Radiotherapy for brain metastases: 2025 update
Abstract
We present the updated recommendations of the Société française de radiothérapie oncologique (the French Society for Radiation Oncology) on the indications and technical modalities of radiotherapy for brain metastases. The management of brain metastases represents a complex therapeutic challenge, due to the increase in patient life expectancy, technological advances in imaging and radiotherapy, specific and relevant prognostic classifications, the increased intracranial efficacy of certain systemic therapies and also the possible iterative irradiation sequences. The prevention of acute and late side effects is essential. Therapeutic strategies defined in a multidisciplinary manner are becoming increasingly personalized and must be rediscussed according to the evolution of the intracranial and extracranial disease.
Source and rights
Published by Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2025
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique




